Ken Fisher Viridian Therapeutics, Inc.\De Transaction History
Fisher Asset Management, LLC
- $213 Billion
- Q1 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Fisher Asset Management, LLC holds 389,087 shares of VRDN stock, worth $4.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
389,087Holding current value
$4.65 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VRDN
# of Institutions
142Shares Held
61.9MCall Options Held
160KPut Options Held
354K-
Paradigm Biocapital Advisors LP New York, NY5.03MShares$60.1 Million3.3% of portfolio
-
State Street Corp Boston, MA4.49MShares$53.6 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$46.4 Million5.84% of portfolio
-
Black Rock Inc. New York, NY3.81MShares$45.6 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.66MShares$43.7 Million1.34% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $477M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...